| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |